Author Profile
Cliff Mintz
Phone: 202-332-8887
1201 New York Ave NW Suite 240
Washington
DC
20005
United States
Channels
- Practice Area
- Administrative Law
- Admiralty & Maritime Law
- Advertising Law
- Alternative Dispute Resolution
- AmLaw 200 Blogs
- Antitrust Law
- Bankruptcy
- Civil Rights & Privacy Law
- Consumer Law
- Corporate & Commercial Litigation
- Criminal Law
- Divorce & Family Law
- Education Law
- Election Law & Political Commentary
- Electronic Discovery
- Employment & Labor Law
- Environmental Law
- General Counsel Blogs
- Immigration Law
- Insurance Law
- Intellectual Property Law
- International Law
- Judiciary Law
- Media, Entertainment & Sports Law
- Law Firm Management & Legal Marketing
- Personal Injury & Medical Law
- Probate & Estate Planning
- Real Estate & Construction Law
- Tax & Financial Law
- Technology
- Whistleblower Law
- Workers' Compensation
- Law School
RSS
About
Cliff Mintz is a former medical school professor, industrial scientist, professional recruiter, management consultant, entrepreneur and career development expert who has been around the block and wants to share his experiences to help others launch successful careers in the bioscience industry. Cliff is currently a freelance writer, blogger and speaker at career fairs and professional meetings
Practice Areas
Education
Recent Articles
Not All Generics Are Created Equal
The generic drug industry didn’t exist until the passage of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Amendments). This piece of legislation, better known in the pharmaceutical industry as the Hatch-Waxman Act, was proposed and adopted by the US Congress...
A Twitter List for Pharma Companies Mark Senak, author of the EyeonFDA blog and "all around good guy," has created a Twitter list that follows the tweets of all of the pharmaceutical companies that use Twitter. Because the list of companies using Twitte
Mark Senak, author of the EyeonFDA blog and “all around good guy,” has created a Twitter list that follows the tweets of all of the pharmaceutical companies that use Twitter. Because the list of companies using Twitter is so small, it is a convenient aggregation tool to monitor the...
A Twitter List for Pharma Companies Mark Senak, author of the EyeonFDA blog and "all around good guy," has created a Twitter list that follows the tweets of all of the pharmaceutical companies that use Twitter. Because the list of companies using Twitte
Mark Senak, author of the EyeonFDA blog and “all around good guy,” has created a Twitter list that follows the tweets of all of the pharmaceutical companies that use Twitter. Because the list of companies using Twitter is so small, it is a convenient aggregation tool to monitor the...
A Twitter List for Pharma Companies
Mark Senak, author of the EyeonFDA blog and “all around good guy,” has created a Twitter list that follows the tweets of all of the pharmaceutical companies that use Twitter. Because the list of companies that are currently using Twitter is so small, it is a convenient aggregation...
Social Media, Regulatory Guidance and Patent Advocacy
Jonathan Richman, author of the Dose of Digital Blog, got it exactly right in today’s post entitled “Patients WILL Have the Final Say on Pharma Social Media” He was spot on with his conclusion that while social media pundits and patient advocacy groups can push FDA to...